Establishment of an induced pluripotent stem (iPS) cell line (SDUKIi006-A) from a 21-year old male patient diagnosed with atypical autism disorder.
Journal
Stem cell research
ISSN: 1876-7753
Titre abrégé: Stem Cell Res
Pays: England
ID NLM: 101316957
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
03
12
2020
revised:
08
01
2021
accepted:
12
01
2021
pubmed:
2
2
2021
medline:
22
6
2021
entrez:
1
2
2021
Statut:
ppublish
Résumé
Autism is a complex neuropsychiatric disorder defined by significant challenges in communication skills and social behavior as well as repetitive conduct and interests. Recent advances in stem cell technologies allow in vitro modeling of the underlying molecular disease mechanisms. Using integration-free episomal plasmids, we have generated a novel iPS cell line (SDUKIi006-A) from a patient diagnosed with atypical autism ("FYNEN cohort" of Southern Denmark). Characterization of the established cell line validated its expression of pluripotency markers, differentiation into the three germ layers, and the absence of chromosomal abnormalities.
Identifiants
pubmed: 33524673
pii: S1873-5061(21)00031-3
doi: 10.1016/j.scr.2021.102185
pii:
doi:
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102185Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.